The Department of Defense is offering the Peer Reviewed Cancer Horizon Award to support junior level scientists in conducting impactful cancer research with the mentorship of an experienced cancer researcher. Junior investigators are encouraged to develop and implement research projects in various cancer fields excluding breast, prostate, lung, or ovarian cancer. Both predoctoral candidates and postdoctoral fellows are eligible to apply, focusing on career development and intellectual growth. Applications must align with specified Topic Areas and demonstrate scientific rationale. The closing date for applications is September 29, 2015.
Opportunity ID: 277596
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-15-PRCRP-HA |
| Funding Opportunity Title: | DoD Peer Reviewed Cancer Horizon Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 13 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 01, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 29, 2015 |
| Current Closing Date for Applications: | Sep 29, 2015 |
| Archive Date: | Oct 29, 2015 |
| Estimated Total Program Funding: | $1,560,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | New for FY15, the Horizon Award supports junior level scientists to conduct impactful research with the mentorship of an experienced cancer researcher (i.e., Mentor). The Horizon Award challenges junior scientists to develop and implement research in the cancer field. This opportunity allows for junior investigators to develop a research project, investigate a problem or question in the field of cancer, and further their intellectual development as a cancer researcher of the future. Under this award mechanism, the junior investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development. It should be clear that the proposed research is intellectually designed by the PI with assistance from the Mentor. Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated. Clinical trials will not be supported by this mechanism. Key elements of the award are as follows: • Principal Investigator (PI): Both predoctoral candidates and postdoctoral fellows are eligible according to the following definitions: ○ Predoctoral candidate: Must have successfully completed coursework and passed any qualifying examinations by the time of the application submission deadline. The predoctoral candidate should be within two years of his/her acceptance as a DoD FY15 Peer Reviewed Cancer Horizon Award 5 doctoral candidate, completed all laboratory rotations, and should be working in his/her Mentor’s laboratory at the time of the application submission deadline. ○ Postdoctoral fellow: Must be within three years of his/her terminal degree (excluding time in residency or on family medical leave) and working in the Mentor’s laboratory at the time of the application submission deadline. The PI’s record of accomplishments (including but not limited to publications, awards, research recognition) will be evaluated regarding his/her potential for contributing to the FY15 PRCRP Topic Area(s) the proposed research addresses. To be considered for funding, applications for the PRCRP Horizon Award must address at least one of the Topic Areas as directed by Congress. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), or ovarian cancer will not be accepted. The FY15 PRCRP Topic Areas are listed below. • Colorectal cancer • Genetic cancer research • Kidney cancer • Listeria vaccine for cancer • Liver cancer (New for FY15) • Melanoma and other skin cancers • Mesothelioma • Myeloproliferative disorders • Neuroblastoma • Pancreatic cancer • Stomach cancer (New for FY15) |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 277596 Full Announcement-1 -> prcrp_fy15 ha pa_gg2.pdf
Folder 277596 Full Announcement-2 -> prcrp fy15 ha pi eligibility statement-final.pdf
Folder 277596 Full Announcement-2 -> fy15 prcrp postdoc academic statement.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00217680 | Jul 01, 2015 | Sep 29, 2015 | View |
Package 1
Mandatory forms
277596 RR_SF424_2_0-2.0.pdf
277596 RR_Budget_1_3-1.3.pdf
277596 RR_KeyPersonExpanded_2_0-2.0.pdf
277596 PerformanceSite_2_0-2.0.pdf
Optional forms
277596 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
